Taylor Wessing sees strong UK growth as global revenue tops €600m

Taylor Wessing has reported another year of double-digit growth, with UK profit per equity partner (PEP) rising to £1.1 million and global revenue hitting €619 million (£526m) for 2024/25 - up 10% year-on-year.

UK revenue rose 15% to £283.7 million, while profit climbed 12.3% to £103 million.

The latest results cap a strong run of growth for the firm’s UK business, which has expanded by 80% since 2020. Recent high-profile mandates include the firm's work for private equity client Inflexion on the sale of skincare brand Medik8 to L'Oréal.

Alongside financial gains, the firm made a series of strategic investments in the year, including 24 global lateral hires since the start of 2024, office upgrades across multiple regions, and the rollout of AI platform Legora in June after a successful pilot.

Last year, the firm committed to reach €1 billion in revenue by the 2028/29 financial year. To achieve that, it will need to hit an average annual growth rate of around 12% over the next four years.

What they said

"We are delighted to see strong growth across our business, as the strategy we implemented is proving effective", said UK managing partner Shane Gleghorn. "Our ongoing focus on premium, high-profile transactions, complex disputes and critical regulatory work in our core sectors is paying dividends."

“I would like to thank everyone at Taylor Wessing for their focus on delivering for our clients in the last year, and the trust those clients place in us."